About Mingjie Pharmaceutical
Mingjie Pharmaceutical is a Healthcare company based in Nanjing (China) founded in 2018, and was acquired by WuXi AppTec in September 2020. Drug quality control solutions are provided for pharmaceuticals. Its focus areas include Biopharma Outsourcing, Consulting, Manufacturing and Quality Control.
Company details
Mingjie Pharmaceutical was established in 2018 and is based in Nanjing, China. Operations focus on the pharmaceutical sector, where drug quality control solutions are developed and supplied. Services include testing, analysis, and compliance tools to ensure product standards. The company serves clients in the healthcare industry across domestic and potential international markets, with activities centered on regulatory adherence and safety protocols.
- Headquarters Nanjing, China
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website mstonepharma.com
- Acquired by WuXi AppTec (Sep 2020)
- Investors
- Acquired byWuXi AppTec
(Sep 2020)
Investors in Mingjie Pharmaceutical
Mingjie Pharmaceutical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include WuXi AppTec.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of CRO and CDMO services | 2000 | wuxiapptec.com | Shanghai, China |
Investor details for Mingjie Pharmaceutical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Mingjie Pharmaceutical
2 dated milestones of Mingjie Pharmaceutical across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Mingjie Pharmaceutical is founded.
- Exit Acquired by WuXi AppTec.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mingjie Pharmaceutical
Complete news archive for Mingjie Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mingjie Pharmaceutical
Mingjie Pharmaceutical was founded in 2018.
Mingjie Pharmaceutical is headquartered in Nanjing, China. It is registered at Nanjing, Jiangsu, China.
Mingjie Pharmaceutical was established in 2018 and is based in Nanjing, China. Operations focus on the pharmaceutical sector, where drug quality control solutions are developed and supplied. Services include testing, analysis, and compliance tools to ensure product standards. The company serves clients in the healthcare industry across domestic and potential international markets, with activities centered on regulatory adherence and safety protocols.
Mingjie Pharmaceutical has 1 investor. Key investors include WuXi AppTec.
Yes. Mingjie Pharmaceutical was acquired by WuXi AppTec in September 2020.